Latest News for: vitiligo
Edit
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
Business Wire 03 Oct 2026
Edit
Vermillion Plain Talk
02 Oct 2026
AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo
RINVOQ is the first and only systemic medication ...
Edit
SCENESSE® response in vitiligo: new cases from the CUV105 trial presented to EADV (Form 6-K) (Clinuvel Pharmaceuticals Limited)
Public Technologies 01 Oct 2026
Edit
Vitiligo Market Forecast 2034: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Pfizer, ...
GetNews 28 Sep 2026
To Know in detail about the Vitiligo market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; ... Vitiligo current marketed and Vitiligo emerging therapies ... Vitiligo market drivers and Vitiligo market barriers.
Edit
Finding your identity with vitiligo: 'There's so much power in being vulnerable and sharing your story'
Canoe 25 Sep 2026
Finding your identity with vitiligo ... Towheed was diagnosed with vitiligo, a skin disorder where pigment-producing cells are destroyed by an overactive immune system, leaving white patches on the body ... His vitiligo is part of his identity.
Edit
Global Vitiligo Treatment Market to Reach USD 2.97 Billion by 2034 at 5.8% CAGR as Rising Disease Prevalence, Growing Aesthetic Awareness, and Advances in Targeted Therapies Accelerate Market Growth, Reports Maximize Market Research
PR Newswire 24 Sep 2026
... Calcineurin Inhibitors, Janus Kinase Inhibitors, Immunomodulators, and Other Dermatological Drugs across Non-Segmental Vitiligo and Segmental Vitiligo ... Non-Segmental Vitiligo; Segmental Vitiligo.
Edit
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
Nasdaq Globe Newswire 19 Sep 2026
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo ... .
Edit
Vietnamese dermatologist shares vitiligo treatment approach at AMSC Malaysia 2026
Vietnam News 17 Sep 2026
Dr Nguyễn Phương Thảo of Pensilia Healthcare System joined the “Manage Pigmentary Disorders in Asian Skin” session in Kuala Lumpur, sharing a multimodal approach to vitiligo treatment that focuses on the skin microenvironment.
Edit
Morgan Citizen
10 Jul 2026
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
Forte Biosciences stock soars after early-stage data show FB102 significantly improves facial depigmentation in vitiligo with a favorable safety profile ... .
Edit
Morgan Citizen
09 Jul 2026
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
Edit
Times Argus
09 Jul 2026
FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
Edit
FB102 ACHIEVES STATISTICALLY SIGNIFICANT IMPROVEMENT IN VITILIGO AT WEEK 24 AFTER COMPLETION OF 12-WEEK TREATMENT PERIOD (Form 8-K) (Forte Biosciences Inc)
Public Technologies 09 Jul 2026
Edit
Vitiligo Market is Projected to Witness Significant Growth by 2036 Owing to the Expansion of ...
GetNews 09 Jul 2026
Edit
Mohali consumer panel orders tattoo studio to refund ₹65k, rejects vitiligo cure claim
Hindustan Times 08 Jul 2026
The commission observed that once the ...
- 1
- 2
- Next page »